Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name AZD0171
Trade Name
Synonyms AZD 0171|AZD-0171
Drug Descriptions

AZD0171 is a monoclonal antibody that targets leukemic inhibitory factor (LIF), leading to decreased downstream signaling, potentially resulting in antitumor activity (Cancer Res 2022;82(12_Suppl):Abstract nr 1293).

CAS Registry Number NA


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AZD0171 AZD0171 0 0
AZD0171 + Carboplatin + Paclitaxel AZD0171 Carboplatin Paclitaxel 0 0
AZD0171 + Durvalumab + Gemcitabine + Nab-paclitaxel AZD0171 Durvalumab Gemcitabine Nab-paclitaxel 0 1

Additional content available in CKB BOOST